FDA Inspection 880454 — NATCO Pharma Limited

NATCO Pharma Limited — FEI 3004540906

The FDA completed an inspection of NATCO Pharma Limited on May 23, 2014 in Rangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rangareddy (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.